|
Insider Trading: Amicus Therapeutics Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amicus Therapeutics Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Amicus Therapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Amicus Therapeutics Inc since 2005.
The reporting company's ticker symbol is FOLD.
The reporting company's CIK number is 1178879.
The total value of stock buying since 2005 is $32,923,404.
The total value of stock sales is $2,509,088.
The total value of stock exercises is $100,902.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Amicus Therapeutics Inc (FOLD) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at Amicus Therapeutics Inc (FOLD) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Amicus Therapeutics Inc (FOLD).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-07 | 0 | 0 | 44,593 | 554,594 | 15,000 | 9,562 |
| 2008-06 | 0 | 0 | 15,000 | 163,743 | 0 | 0 |
| 2008-05 | 0 | 0 | 10,000 | 105,234 | 0 | 0 |
| 2008-04 | 0 | 0 | 41,950 | 453,347 | 20,000 | 12,750 |
| 2008-03 | 428,376 | 13,714,797 | 10,000 | 100,000 | 0 | 0 |
| 2008-02 | 1,292,086 | 12,832,319 | 35,500 | 355,709 | 22,083 | 14,088 |
| 2008-01 | 113,700 | 1,138,683 | 10,000 | 103,051 | 20,000 | 12,760 |
| 2007-12 | 0 | 0 | 0 | 0 | 15,000 | 9,570 |
| 2007-08 | 60,200 | 692,220 | 0 | 0 | 32,366 | 20,649 |
| 2007-07 | 119,000 | 1,356,382 | 0 | 0 | 0 | 0 |
| 2007-06 | 281,842 | 3,189,003 | 44,894 | 673,410 | 33,736 | 21,523 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Amicus Therapeutics Inc (FOLD)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-07-17 | Bloch Stephen M (Director) | Sale | 1,600 | 13.38 | 21,401 |
| 2008-07-16 | Bloch Stephen M (Director) | Sale | 1,900 | 13.16 | 25,007 |
| 2008-07-15 | Licholai Gregory P (VP, Medical Affairs) | Sale | 15,000 | 13.00 | 195,000 |
| 2008-07-15 | Licholai Gregory P (VP, Medical Affairs) | Option Exercise | 15,000 | .64 | 9,562 |
| 2008-07-15 | Bloch Stephen M (Director) | Sale | 5,600 | 12.90 | 72,212 |
| 2008-07-14 | Bloch Stephen M (Director) | Sale | 1,600 | 12.61 | 20,171 |
| 2008-07-11 | Bloch Stephen M (Director) | Sale | 8,893 | 12.55 | 111,607 |
| 2008-07-07 | Crowley John F (President and CEO) | Sale | 2,200 | 11.09 | 24,392 |
| 2008-07-03 | Crowley John F (President and CEO) | Sale | 1,500 | 10.84 | 16,266 |
| 2008-07-02 | Crowley John F (President and CEO) | Sale | 3,000 | 11.05 | 33,150 |
| 2008-07-01 | Crowley John F (President and CEO) | Sale | 3,300 | 10.72 | 35,388 |
| 2008-06-20 | Patterson Matthew R (Chief Operating Officer) | Sale | 1,400 | 11.38 | 15,932 |
| 2008-06-19 | Patterson Matthew R (Chief Operating Officer) | Sale | 400 | 11.05 | 4,421 |
| 2008-06-18 | Patterson Matthew R (Chief Operating Officer) | Sale | 1,500 | 11.01 | 16,512 |
| 2008-06-17 | Patterson Matthew R (Chief Operating Officer) | Sale | 1,800 | 11.08 | 19,945 |
| 2008-06-16 | Patterson Matthew R (Chief Operating Officer) | Sale | 4,900 | 11.18 | 54,802 |
| 2008-06-04 | Crowley John F (President and CEO) | Sale | 5,000 | 10.43 | 52,131 |
| 2008-05-02 | Crowley John F (President and CEO) | Sale | 4,795 | 10.45 | 50,091 |
| 2008-05-01 | Crowley John F (President and CEO) | Sale | 5,205 | 10.59 | 55,143 |
| 2008-04-24 | Palling David (Senior VP, Drug Development) | Option Exercise | 20,000 | .64 | 12,750 |
| 2008-04-16 | Patterson Matthew R (Chief Operating Officer) | Sale | 578 | 10.00 | 5,780 |
| 2008-04-15 | Patterson Matthew R (Chief Operating Officer) | Sale | 3,422 | 10.17 | 34,809 |
| 2008-04-14 | Patterson Matthew R (Chief Operating Officer) | Sale | 6,000 | 10.61 | 62,988 |
| 2008-04-03 | Crowley John F (President and CEO) | Sale | 3,600 | 11.03 | 39,692 |
| 2008-04-02 | Crowley John F (President and CEO) | Sale | 11,600 | 11.04 | 128,036 |
| 2008-04-01 | Palling David (Senior VP, Drug Development) | Sale | 1,250 | 11.15 | 13,932 |
| 2008-04-01 | Crowley John F (President and CEO) | Sale | 2,400 | 11.10 | 26,633 |
| 2008-03-10 | Topper James N (Director) | Purchase | 5,500 | 10.21 | 56,669 |
| 2008-03-10 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 5,500 | 10.21 | 56,669 |
| 2008-03-06 | Topper James N (Director) | Purchase | 22,146 | 10.00 | 221,362 |
| 2008-03-06 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 22,146 | 10.00 | 221,362 |
| 2008-03-05 | Topper James N (Director) | Purchase | 50,000 | 9.77 | 490,585 |
| 2008-03-05 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 50,000 | 9.77 | 490,585 |
| 2008-03-04 | Crowley John F (President and CEO) | Sale | 5,503 | 10.00 | 55,030 |
| 2008-03-04 | Topper James N (Director) | Purchase | 13,500 | 9.83 | 133,349 |
| 2008-03-04 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 13,500 | 9.83 | 133,349 |
| 2008-03-03 | Crowley John F (President and CEO) | Sale | 4,497 | 10.00 | 44,970 |
| 2008-03-03 | Topper James N (Director) | Purchase | 62,100 | 268.09 | 10,124,128 |
| 2008-03-03 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 62,100 | 9.80 | 605,475 |
| 2008-02-29 | Crowley John F (President and CEO) | Option Exercise | 10,000 | .64 | 6,380 |
| 2008-02-29 | Topper James N (Director) | Purchase | 8,637 | 9.88 | 85,335 |
| 2008-02-29 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 8,637 | 9.88 | 85,335 |
| 2008-02-28 | Palling David (Senior VP, Drug Development) | Sale | 2,500 | 10.51 | 26,264 |
| 2008-02-28 | Licholai Gregory P (VP, Medical Affairs) | Sale | 10,000 | 10.04 | 100,445 |
| 2008-02-28 | Topper James N (Director) | Purchase | 7,800 | 9.99 | 78,282 |
| 2008-02-28 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 7,800 | 9.99 | 78,282 |
| 2008-02-27 | Topper James N (Director) | Purchase | 23,300 | 9.92 | 230,292 |
| 2008-02-27 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 23,300 | 9.92 | 230,292 |
| 2008-02-26 | Topper James N (Director) | Purchase | 8,000 | 9.90 | 78,389 |
| 2008-02-26 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 8,000 | 9.90 | 78,389 |
| 2008-02-25 | Topper James N (Director) | Purchase | 9,700 | 9.66 | 93,738 |
| 2008-02-25 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 9,700 | 9.66 | 93,738 |
| 2008-02-22 | Topper James N (Director) | Purchase | 8,814 | 9.79 | 86,406 |
| 2008-02-22 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 8,814 | 9.79 | 86,406 |
| 2008-02-21 | Patterson Matthew R (Chief Operating Officer) | Option Exercise | 12,083 | .64 | 7,708 |
| 2008-02-21 | Topper James N (Director) | Purchase | 5,500 | 10.23 | 56,277 |
| 2008-02-21 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 5,500 | 10.23 | 56,277 |
| 2008-02-20 | Topper James N (Director) | Purchase | 49,500 | 9.61 | 475,486 |
| 2008-02-20 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 49,500 | 9.61 | 475,486 |
| 2008-02-19 | Topper James N (Director) | Purchase | 9,600 | 9.90 | 95,063 |
| 2008-02-19 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 9,600 | 9.90 | 95,063 |
| 2008-02-15 | Topper James N (Director) | Purchase | 6,900 | 10.48 | 72,346 |
| 2008-02-15 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 6,900 | 10.48 | 72,346 |
| 2008-02-13 | Topper James N (Director) | Purchase | 12,000 | 10.39 | 124,601 |
| 2008-02-13 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 12,000 | 10.39 | 124,601 |
| 2008-02-12 | Topper James N (Director) | Purchase | 9,400 | 10.04 | 94,394 |
| 2008-02-12 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 9,400 | 10.04 | 94,394 |
| 2008-02-11 | Topper James N (Director) | Purchase | 5,700 | 10.05 | 57,272 |
| 2008-02-11 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 5,700 | 10.05 | 57,272 |
| 2008-02-08 | Topper James N (Director) | Purchase | 33,800 | 10.12 | 342,123 |
| 2008-02-08 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 33,800 | 10.12 | 342,123 |
| 2008-02-07 | Topper James N (Director) | Purchase | 25,400 | 10.09 | 256,219 |
| 2008-02-07 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 25,400 | 10.09 | 256,219 |
| 2008-02-06 | Topper James N (Director) | Purchase | 45,477 | 10.12 | 460,454 |
| 2008-02-06 | Frazier Affiliates Iv Lp (10% Owner) | Purchase | 45,477 | 10.12 | 460,454 |
| 2008-02-05 | Fhm V, Llc (10% Owner) | Purchase | 68,400 | 10.33 | 706,075 |
| 2008-02-05 | Topper James N (Director) | Purchase | 68,400 | 10.33 | 706,075 |
| 2008-02-04 | Fhm V, Llc (10% Owner) | Purchase | 59,175 | 10.28 | 609,566 |
| 2008-02-04 | Topper James N (Director) | Purchase | 59,175 | 10.28 | 609,566 |
| 2008-02-01 | Palling David (Senior VP, Drug Development) | Sale | 3,000 | 10.00 | 30,000 |
| 2008-02-01 | Crowley John F (President and CEO) | Sale | 10,000 | 10.00 | 100,000 |
| 2008-02-01 | Licholai Gregory P (VP, Medical Affairs) | Sale | 10,000 | 9.90 | 99,000 |
| 2008-02-01 | Fhm V, Llc (10% Owner) | Purchase | 80,000 | 9.39 | 756,708 |
| 2008-02-01 | Topper James N (Director) | Purchase | 80,000 | 9.26 | 756,708 |
| 2008-01-31 | Fhm V, Lp (10% Owner) | Purchase | 22,885 | 10.00 | 228,857 |
| 2008-01-31 | Fhm V, Llc (10% Owner) | Purchase | 15,015 | 9.97 | 150,704 |
| 2008-01-31 | Topper James N (Director) | Purchase | 37,900 | 9.99 | 379,561 |
| 2008-01-02 | Crowley John F (President and CEO) | Sale | 10,000 | 10.31 | 103,051 |
| 2008-01-02 | Crowley John F (President and CEO) | Option Exercise | 20,000 | .64 | 12,760 |
| 2007-12-14 | Crowley John F (President & CEO) | Option Exercise | 5,000 | .64 | 3,190 |
| 2007-12-13 | Crowley John F (President & CEO) | Option Exercise | 10,000 | .64 | 6,380 |
| 2007-08-24 | Sblendorio Glenn (Director) | Purchase | 1,000 | 11.42 | 11,420 |
| 2007-08-15 | Patterson Matthew R (Chief Operating Officer) | Option Exercise | 32,366 | .64 | 20,649 |
| 2007-08-08 | Fhm V, Llc (10% Owner) | Purchase | 29,600 | 11.50 | 340,400 |
| 2007-08-08 | Topper James N (Director) | Purchase | 29,600 | 11.50 | 340,400 |
| 2007-07-27 | Fhm V, Llc (10% Owner) | Purchase | 17,800 | 11.37 | 202,341 |
| 2007-07-27 | Topper James N (Director) | Purchase | 17,800 | 11.37 | 202,341 |
| 2007-07-26 | Fhm V, Llc (10% Owner) | Purchase | 8,000 | 11.39 | 91,116 |
| 2007-07-26 | Topper James N (Director) | Purchase | 8,000 | 11.39 | 91,116 |
| 2007-07-25 | Fhm V, Llc (10% Owner) | Purchase | 29,700 | 11.42 | 339,176 |
| 2007-07-25 | Topper James N (Director) | Purchase | 29,700 | 11.42 | 339,176 |
| 2007-06-29 | Topper James N (Director) | Purchase | 13,900 | 11.46 | 159,224 |
| 2007-06-29 | Frazier Healthcare Iv Lp (10% Owner) | Purchase | 13,900 | 11.46 | 159,224 |
| 2007-06-28 | Topper James N (Director) | Purchase | 9,015 | 11.44 | 103,128 |
| 2007-06-28 | Frazier Healthcare Iv Lp (10% Owner) | Purchase | 4,281 | 11.49 | 49,188 |
| 2007-06-27 | Topper James N (Director) | Purchase | 144,400 | 11.22 | 1,624,809 |
| 2007-06-21 | Crowley John F (President & CEO) | Option Exercise | 33,736 | .64 | 21,523 |
| 2007-06-05 | Trainor Iii Eugene A (10% Owner) | Sale | 6,408 | 15.00 | 96,120 |
| 2007-06-05 | Hirsch Russell C (10% Owner) | Sale | 6,427 | 15.00 | 96,405 |
| 2007-06-05 | Barkas Alexander E (Director) | Sale | 6,427 | 15.00 | 96,405 |
| 2007-06-05 | Perry Mark W (10% Owner) | Sale | 6,408 | 15.00 | 96,120 |
| 2007-06-05 | Barris Peter J (10% Owner) | Sale | 6,408 | 15.00 | 96,120 |
| 2007-06-05 | Kramlich C Richard (10% Owner) | Sale | 6,408 | 15.00 | 96,120 |
| 2007-06-05 | Newhall Charles W Iii (10% Owner) | Sale | 6,408 | 15.00 | 96,120 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Amicus Therapeutics Inc (symbol FOLD,
CIK number 1178879) see
the Securities and Exchange Commission (SEC) website.
|
|
